UK markets closed
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • FTSE 250

    23,608.79
    -221.39 (-0.93%)
     
  • AIM

    1,268.15
    -4.25 (-0.33%)
     
  • GBP/EUR

    1.1676
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.3678
    -0.0043 (-0.31%)
     
  • BTC-GBP

    30,622.52
    -1,585.74 (-4.92%)
     
  • CMC Crypto 200

    1,041.14
    -61.92 (-5.61%)
     
  • S&P 500

    4,447.62
    -1.36 (-0.03%)
     
  • DOW

    34,749.42
    -15.40 (-0.04%)
     
  • CRUDE OIL

    73.76
    +0.46 (+0.63%)
     
  • GOLD FUTURES

    1,751.60
    +1.80 (+0.10%)
     
  • NIKKEI 225

    30,248.81
    +609.41 (+2.06%)
     
  • HANG SENG

    24,192.16
    -318.82 (-1.30%)
     
  • DAX

    15,531.75
    -112.22 (-0.72%)
     
  • CAC 40

    6,638.46
    -63.52 (-0.95%)
     

This Explosive Biotech Is Taking On a Huge New Market

·7-min read
This Explosive Biotech Is Taking On a Huge New Market
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Dominant in its core reproductive health market, niche medical diagnostics company Natera now has its sights on the crowded oncology diagnostics space.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting